The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease. by Howat, J. M. et al.
Br. J. Cancer (1983), 47, 629-640
The association of cytosol oestrogen and progesterone
receptors with histological features of breast cancer and
early recurrence of disease
J.M.T. Howatl*, D.M. Barnes2, M. Harris3 & R. Swindell4
1Department ofSurgery, University Hospital ofSouth Manchester, Withington; 2Department ofClinical
Research, 3Department ofPathology, and 4Department ofMedical Statistics, Christie Hospital and Holt
Radium Institute, Manchester.
Summary Two hundred and eighty-eight primary breast tumours were examined for the presence or absence
of oestrogen (RE,) and progesterone (RPj) receptors. Analysis has shown a relative interdependence between
the steroid receptor status of primary breast cancer and other prognostic variables such as histological grade,
lymphocytic infiltration and tumour elastosis. There were significant associations between epithelial cellularity,
stromal fibrosis and the value of REC in those tumours in which the receptor was present. Cellularity and
fibrosis were unrelated to the presence or absence of oestrogen receptor. By contrast, neither the presence or
absence nor the value of RPC could be related to cellularity or fibrosis. The value of REc and RPc analysis as
an indicator of prognosis was examined in a sub-group of 175 patients receiving no additional treatment
following mastectomy. Overall relapse-free survival (RFS) was no different for those patients with receptors
compared to those without them (REC P=0.11, RPr P=0.7). There was no difference in RFS of receptor
positive and negative tumours when the axillary node status was taken into account.
Increased recognition of the importance of selective
hormone binding in initiating steroid action in
target tissues has led to the study of oestrogen and
progesterone binding by human breast cancer.
Though the receptor content of the primary tumour
is reported to be independent of factors such as
tumour site or size, age of patient or degree of
axillary node involvement (Knight et al., 1977) it is
not known to what degree tumour differentiation is
under endocrine control. Studies linking receptors
and hormone-dependent proteins with
morphological and clinical features may help
clinicians to recognise tumours which are hormone-
sensitive. In early studies of this nature there was
no consistent relationship between specific
histopatholdgical features of the tumour and either
the presence or the value of REr (Sander, 1968;
Korenman & Dukes, 1970; Johansson et al., 1970;
Feherty et al., 1971; Wittliff et al., 1971; LeClercq et
al., 1973; Terenius et al., 1974; Aspergren &
Hakansson, 1974). However, in some of these
studies numbers were small and methods of REC
analysis and morphological examination were
inconsistent. More recent studies have shown that
REC may be closely related to tumour grade
(Maynard et al., 1978; Martin et al., 1979b;
Rasmussen et al., 1981; Thoresen et al., 1981), to the
histological type and degree of lymphocytic
infiltration of primary tumour (Rosen et al., 1975)
and to the presence or absence of elastosis in the
tumour stroma (Masters et al., 1976). Similar links
have been recognised between the progesterone
receptor (RPc) and histological grade and elastosis
(Martin et al., 1979b; Rolland et al., 1980), but a
relationship between RPC and other aspects of
tumour morphology has not been reported.
Most investigators who have studied the
relationship between REC and freedom from
recurrence and survival, have suggested that an
earlier recurrence and shorter survival may be
expected in those patients who lack REC in their
primary tumour, although data vary as to which
patients obtain the greatest benefit (Knight et al.,
1977; Maynard et al., 1978; Bishop et al., 1979;
Cooke et al., 1979; Allegra et al., 1979; Forrest et
al., 1980; Westerberg et al., 1980; Croton et al.,
1981). As the REC is said to be independent of other
prognostic variables in breast cancer, the
measurement of this receptor has been advocated as
a means of selecting patients likely to benefit most
from systemic adjuvant therapy (Cooke et al., 1980).
By contrast, Hilf and his colleagues (1980) were
unable to confirm that REC has any beneficial effect
on the disease process.
Similar studies which link the presence or absence
of RPC to relapse-free survival (RFS), have also
produced conflicting results (Pichon et al., 1980;
Allegra et al., 1979; Kinne et al., 1981) and the role
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of this receptor as a prognostic factor in breast
cancer remains uncertain.
The objectives of this single centre study were
twofold: to test the hypothesis that the presence or
absence of RE, and RP, is a reflection of certain
morphological features of the tumour, some of
which are of prognostic significance in their own
right and to investigate the role of REc and RPc as
indicators of early recurrence.
Materials and methods
Oestrogen andprogesterone receptor assay
Samples of histologically proven primary tumours
from women with breast cancer were studied.
Portions for oestrogen (RE,) and progesterone
(RPj) receptor measurement were selected at the
time of surgery by the pathologist who received
tissue for frozen section. They were stored in
liquid nitrogen until required for analysis, and then
homogenised and centrifuged. The receptor content
of the cytosol was measured by incubation with
either tritiated oestradiol in the presence or absence
of diethyl-stilboestrol as a competitor for specific
oestrogen receptor sites, or tritiated R5020 and
radio-inert R5020, a synthetic progestin, for specific
progesterone receptor sites. Non-receptor bound
[3H]-hormone was separated from hormone bound
to receptors by adsorption on to Dextran-coated
charcoal (DCC). The activity of the receptor-bound
radio-labelled hormone remaining in the
supernatant was measured in a scintillation counter
and the data analysed according to Scatchard
(1949). Values >5fMmg 1 for REC and
>15fMmg-1 for RPC of cytosol protein were
regarded as positive (Barnes et al., 1977; Skinner et
al., 1980). Negative results from tumours where the
cytosol protein was <0.7mgml- were not
accepted as valid and were excluded from the study.
Histology
The pathological features of 288 unselected primary
malignant breast tumours were reviewed
retrospectively by one pathologist who was
unaware of the receptor status. His observations
were based on the examination of routine paraffin
wax embedded sections stained with haematoxylin
and eosin and sections stained for elastic tissue with
Miller's Victoria blue and Van Geison stain. The
following pathological observations were made: the
maximum diameter, the nature of the margin
(circumscribed or stellate), and the histological type
of the primary tumour. The grade of infiltrating
duct tumours was assessed on a scale of 1 (well-
differentiated) to 3 (poorly-differentiated) taking into
account tubular differentiation, nuclear
pleomorphism and mitotic activity according to the
method recommended by Scarff & Torloni (1968)
which is essentially that of Bloom & Richardson
(1957). The degree of lymphoid reaction in and
around the primary tumour was evaluated on a
scale of 1 (slight or none) to 3 (marked), and the
epithelial cellularity of the middle and the edge of
the tumour, the stromal reaction or fibrosis within
the tumour and the degree of elastic tissue
formation within the stroma were similarly assessed.
This is a semi-quantitative visual assessment based
on the experience of the pathologist.
Assessment ofrecurrence
The relationship of the RE, and RP, status to the
development of early recurrence of the disease was
studied in a subgroup of 175 patients with operable
disease (T1-3No01MO). Each had a Patey modified
radical mastectomy. After histological examination
of the axillary nodes, the patients were classified
into three groups: those with no nodes containing
tumour; those with 1-3 nodes containing tumour;
and patients with 4 or more nodes containing
tumour. Patients with bilateral tumours, or distant
metastases and those receiving adjuvant hormone
or cytotoxic therapy were excluded from this part
of the study.
The patients were examined one month after
operation, then every 6 weeks for 2 years and
thereafter annually. Local recurrence and nodal
disease was confirmed where possible by biopsy
while distant bone and visceral metastases were
diagnosed on unequivocal radiological evidence.
Statistical methods
The Chi-squared test was used to test for
association between histological features and
receptor status in r x c contingency tables. The
relationship between RE, and RPr content and
degrees of cellularity, fibrosis, lymphocytic
infiltration, elastosis and histological grade was
examined by means of the Kruskal Wallis non-
parametric one-way Analysis of Variance (ANOVA).
For studies of RFS time-based curves were
computed by actuarial methods and compared by
the log-rank test (Peto et al., 1977).
Results
Receptor status and age
The subgroups of patients analysed in relation to
histology (288) or recurrence of disease (175) were
shown statistically to be similar in composition in
terms of age, menopausal status, and frequency of
receptor-positive tumours, to an overall group ofHORMONE RECEPTORS IN EARLY BREAST CANCER 631
523 consecutive patients with breast cancer studied
in a 4-year period, but in whom complete
histological or follow-up data was not available.
Sixty per cent of the patients had tumours
containing REc and 40%, RP,. Fifty-three per cent
of premenopausal and 62o," of postmenopausal
patients possessed REC. Absolute values of REC
showed a statistically significant association with
age, being higher in older women and confirming a
previous observation from our laboratory (Skinner
et al., 1980). For RPC the proportions of receptor-
positive premenopausal (430() and postmenopausal
(38%) patients were similar and age had no
influence on the value of RPC.
Receptor status and pathological parameters
The morphological and histological features of 288
primary tumours were studied in relation to both
the receptor status, and in receptor-positive
tumours, to the value of REC and RPC. There was
no relationship between the presence or absence of
REC and RPC and either the diameter of the tumour
or whether the margins were circumscribed or
infiltrative. The relationship between receptor status
and histological type of tumour is shown in Table I.
All of the tubular carcinomas contained RE, and
RPC, and 70% of the infiltrating lobular carcinomas
contained REC. However, the numbers of some
types of tumour were too small to permit statistical
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Table I Relationship of histological type of primary
tumour to oestrogen and progesterone receptor status
RE, RP,
No. No.
Histological tYvpe positite (0,,) positive (0O)
Intraduct 5 '9 (55) 3/9 (33)
Infiltrating duct* 148/248 (60) 100/233 (43)
Infiltrating papillary 11 (100)
Mucoid 5/8 (63) 1/8 (13)
Medullary 0 3 (0) 0/3 (0)
Infiltrating lobular 7/10 (70) 4/10 (40)
Tubular 7/7 (100) 5/5 (100)
Sarcoma 0/2 (0) 0/2 (0)
*All grades.
Histological gr-acle
REC was measured in 157 and RPC in 142
infiltrating duct carcinomas in which grade was
assessed. There was a highly significant association
between the presence or absence of both types of
receptor and the histological grade (REC vs. grade
P=0.0004: REC vs. grade P=0.0001). REC and RPC
occurred most frequently in grade 1 (well-
differentiated) tumours whereas there were
relatively few receptor-positive tumours in grade III
(poorly-differentiated) (Figure 1). In receptor-
positive tumours there was no association between
grade and value of either REc (P=0.6) or RPc
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Figure 1 Relationship of RE, and RP, to grade of infiltrating duct tumours.632 J.M.T. HOWAT et al.
(P=0.8). Specific types of tumours, e.g. lobular,
medullary and tubular, were not graded and were
excluded from this section.
Cellularity andfibrosis
In those tumours in which receptors were found
there was a significant association between
cellularity, both at the centre and at the edge of the
tumour, and the value of REr (P<0.0001) (Figure 2)
although cellularity was unrelated to the presence
or absence of REc (REC vs. cellularity edge, P=0.7;
centre, P=0.1). Tumour cellularity was not related
to either the value of RPc (edge, P=0.2; centre, P
=0.3), or to the presence or absence of this receptor
(RPC vs. cellularity centre, P=0.5; edge, P=0.8). In
REV-positive tumours there was an inverse
association between the degree of stromal fibrosis
and value of REC, those tumours with most fibrosis
containing lowest values of receptor (P<0.0001)
although there was no association between the
degree of fibrosis and the presence or absence of
REr (P=0.2). Fibrosis was not related to either the
presence or the value of RPc (P=0.2, P=0.5).
Elastosis
REC and RPC were found in 72% (32/44) and 59%
(23/39) respectively of those tumours with a marked
degree of elastic tissue within the stroma compared
with 67% (37/55) and 36% (17/47) of tumours with
moderate elastosis and 49% (36/73) and 26% (18/68)
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Figure 2 RE, values related to cellularity assessed at
the tumour edge. Median value and upper and lower
quartiles shown.
of those with none. For both REC and RPC these
were statistically significant associations (REC vs.
elastosis, P=0.02; RPC vs. elastosis, P=0.004)
(Figure 3). There was no association between degree
of elastosis and value of either RE, or RPc (P=0.4).
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Figure 3 Relationship of RE, and RP, to the degree of elastic tissue formation in primary breast cancer.
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l_Vnmphocitic in?filtracition
Only 30o^ (9/30) of tumours with a marked
lymphocytic infiltrate were found to contain RE, in
contrast with 73O, (69/94) of tumours with no
lymphocytic reaction (P=0.0001). A similar inverse
association was found for RPC. Ninety-three per
cent of tumours with a marked lymphocytic
reaction were RPC negative (P=0.0004) (Figure 4).
There was no association between the degree of
lymphocytic infiltration and the value of either
receptor (REC, P =0.9; RPc, P =0.3).
Inter-relationiships of grale, lmipjhocItic inifiltraCltion
andlCI elastosiS
There was a highly significant association between
the degree of lymphocytic infiltration and
histological grade of infiltrating duct tumours
(Table II). High grade tumours contained the most
marked lymphoid reaction (P<0.0001). Table III
summarizes the inverse association between the
degree of elastosis and histological grade, elastosis
being most marked in grade I tumours (P=0.0001).
Receptor statuis aind nio(le nietastases
There was no association between the receptor
status of the primary tumour and the number of
axillary lymph nodes containing metastases (RE us.
nodes, P=0.3; RPC vs. nodes, P=0.7). The
histological findings are summarized in Table IV.
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Table 11 Frequency of concurrence of each
degree of lymphocytic infiltration and
histological grade in 183 infiltrating duct
tumours
L!vmphocYticitifiltrat io(
iVone Modera(Ite Markcd
Grade I (n=49) 34 14 1
Grade!! (ni=94) 52 29 13
Grade III (n=40) 4 20 16
(P= <0.0001).
Table III Frequency of concurrence of each
degree of elastosis and histological grade in 172
infiltrating duct tumours
Ela.stosis
None Present Mtarked
Grade I (n =48) 14 12 22
Grade II (n=85) 30 35 20
Grade III (n=39) 25 12 2
(P =0.0001).
Receptors anId r-ecetarrence rate.s
When the follow-up data were analysed neither age
nor menopausal status at the time of first
presentation had any influence on the recurrence
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Figure 4 Relationship of RE, and RP, to degree of lymphocytic infiltrationi of primary breast cancers.634 J.M.T. HOWAT et al.
Table IV Summary of relationship ofRE, and RP, receptor status to histological observations
Association with Association with
oestrogen receptor Progesterone receptor
Histological observation (REJ) (RPj)
Diameter ofprimary tumour None None
Margin of primary tumour None None
Histological type Statistically none, but all tubular Statistically none, but all
and most lobular tumours RE, +ve tubular tumours RPC +ve
Grade of infiltrating duct tumours REC occur most frequently RPC occur most frequently
in grade I (well-differentiated) in grade I (well-differentiated)
tumours (P=0.0004) tumours (P=0.0001)
Lymphocytic infiltration Inverse association between Inverse association between
lymphoid reaction and presence lymphoid reaction and presence
of REC (P=0.0001) of RPc (P=0.0004)
Epithelial cellularity: In REc+ve tumours, highest values none
in most cellular tumours (post-
menopausal) (P<0.001) but unrelated
to receptor status
Stromal fibrosis In REc+ve tumours, lowest values None
in those tumours with marked fibrosis
(postmenopausal) (P<0.0001) but
unrelated to receptor status.
Elastosis REC occur most frequently in tumours RPC occur most frequently in
with elastosis (P=0.02) tumours with elastosis (P=0.004)
Number of axillary nodes containing None None
tumour
rate of the tumour. The presence or absence or REC
and RPC was analysed with respect to the RFS 15
and 29 months after the last patient entered the
study. At a median observation period of 24
months, a statistically significant increase in RFS
was found for patients who possessed REC
compared with those who lacked this receptor (P
=0.02). This difference was no longer significant at
a median period of observation of 34 months
(Figure 5). When the patients were divided into 4
groups according to the REc content of the tumour
(REC negative, 5-30, 31-100, > 100fMmg-I cytosol
protein) there was no statistical relationship
between RFS and the REC value at any time (Figure
6). In 163 patients RPc was also measured. The
presence of this receptor was not related to RFS
(Figure 7). This was noted in both REc positive and
REC negative tumours, although the number of
patients who possessed RPC and lacked REC was
very small.
The importance of the presence of metastases in
the ipsilateral axillary nodes in determining the
prognosis in breast cancer has been emphasised
(Say & Donegan, 1974; Fisher et al., 1975). This was
confirmed in the present study. The overall
recurrence rate was significantly higher in node
+ve patients regardless of their receptor status
(P<0.001). Three years after mastectomy 80% of
patients without axillary node involvement
remained free from recurrence compared with 56%
of those who had 1-3 involved nodes and less than
30% of patients with 4 or more nodes containing
tumour.
RFS was analysed in relation to receptor status
and axillary node involvement (Figure 8). There was
no statistically significant difference in the RFS
between REC +ve and REC -ve tumours in
patients without axillary metastases (P>0;9) or in
patients with extensive nodal disease (.4) (P=0.2).
In patients with 1-3 axillary nodes involved, RE,
+ve tumours were associated with a longer RFS
than REC -ve tumours at a median observation
period of 24 months (P=0.05), but not at 34
months (P=0.07). There were no differences
between the RFS of RPc +ve and RPc -ve
tumours in any axillary node subgroup.
Discussion
Breast cancer varies in its responsiveness to
hormones, and is the first disease in which
estimation of tissue receptors at the time of initial
surgery has been advocated as a method of
identifying patients with the greatest risk of
recurrence. The purpose of this study was to
examine inter-relationships between steroid receptor
activity and a variety of histological features, and toHORMONE RECEPTORS IN EARLY BREAST CANCER 635
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Figure 5 Effect ofRE, status on relapse-free survival.
assess the value of REC and RPC as independent
factors in the prognosis of breast cancer.
We have shown REC and RPC to be independent
of certain factors known to influence the natural
history of the disease, for example tumour size, and
the nature of its margin and axillary metastases
(Fisher et al., 1975). Although we could not show a
statistical relationship between receptors and the
histological type it is interesting to note that all
tubular carcinomas had both REC and RPC. This
confirms the observation of Antoniades & Spector
(1979). We also confirmed reports of a high
incidence of REC in invasive lobular tumours
(Rosen et al., 1975; Antoniades & Spector, 1979;
Martin et al., 1979b; Rasmussen et al., 1981). Other
workers have failed to demonstrate any such
association (Johansson et al., 1970; Feherty et al.,
1971; Wittliff et al., 1971; LeClercq et al., 1973;
Aspegren & Hakansson, 1974), but in most series
the majority of tumours were infiltrating duct
carcinomas and, as in the present study, the number
of uncommon histological types was too small to
permit statistical evaluation. The finding that both
invasive lobular and tubular carcinomas have a
high incidence of REC supports the hypothesis that
they are extreme variants of the same histological
entity (Eusebi et al., 1979).
Although in the past it was generally accepted
that there was no association between the presence
of REC and the histological features of infiltrating
duct tumours (Johansson et al., 1970; Feherty et al.,
1971; Rosen et al., 1975), only Feherty used the
W.H.O. recommended system of grading. More
recently, using this method exclusively, Maynard et
al. (1978), Martin et al. (1979b), Rasmussen et al.
(1981) and Thoresen et al. (1981) have shown a
definite relationship between histological grade and
REC.
Our data agree with the latter reports and in
addition have confirmed the findings of Martin et
al. (1979b) that the possession of RPC is also linked
to histological grade. Terenius et al. (1974) was
unable to show a relationship between the presence
or absence of RE, and grade, but found that REC
values were statistically higher in well-differentiated
tumours. The method of grading was not specified.
In the present study, as in that of Heusen et al.
(1975) and Thoresen et al. (1981), the mean value of
the receptors was similar in all three grades, and
thus the significance of the association between
grade and presence or absence of receptor is
difficult to interpret. Silvestrini et al. (1979) using
thymidine-labelling indices have shown that
tumours with rapid rates of cell division have a low
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Figure 6 Effect of REC value on relapse-free survival.
incidence of REC. This, and the frequency with
which receptors are found in low grade tumours
suggests that receptors are associated in some way
with low rates of cellular replication.
Cellularity, when assessed both at the centre and
the edge of the tumour to avoid sampling errors,
was unrelated to the presence of REc and RP,.
However, in receptor-positive tumours, there was a
significant association between the highest values of
REC and those tumours with the most abundant
epithelial component. This was found both in the
overall group and post-menopausal patients but not
in pre-menopausal patients. Conversely, those
tumours with the most marked stromal reaction
had the lowest REC values. Once again this was not
seen in the pre-menopausal patients. By contrast,
MONTHS
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Figure 7 Effect of RPC status on relapse-free survival.
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Figure 8 Effect of REC status and node involvement on relapse-free survival.
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the mean value of the progesterone receptors was
similar for all degrees of cellularity. These findings
are identical with those of Masters et al. (1978) and
similar, in part, to the results of Terenius et al.
(1974), Antoniades & Spector (1979) and Martin et
al. (1979a). Rosen et al. (1975) observed some
association between cellularity and RE, value but
did not consider it significant. Feherty et al. (1971)
and Rasmussen et al. (1981) were unable to
show this association. The failure to demonstrate
such a link may be the result of unavoidable
variation in methods used to assess cellularity
(Antoniades & Spector, 1979).
It seems that although cellularity does not affect
the frequency with which receptor-positive tumours
are identified, it does influence the value of REC
when present and therefore REc negativity, based
on a low receptor value, should be considered with
caution in tumours of low cellularity for it may
only reflect the lack of epithelial cells (Martin et al.,
1979a). As the presence of RPr is normally closely
linked with REC (Martin et al., 1979b) the
dissociation of REC and RPC in relation to
cellularity is unexplained.
There is no readily apparent explanation for the
observation that receptors occur infrequently in
tumours with a prominent lymphocytic infiltration,
a relationship which has been reported previously
(Rosen et al., 1975). It seems unlikely that
lymphocytes per se are responsible for the absence
of receptors within a tumour and this inverse
association may merely reflect the observed
statistically significant association between heavy
lymphoid infiltration and poorly differentiated
tumours. A lymphoid reaction is known to be
closely related to the degree of malignancy (Fisher
et al., 1975).
The association of hormone receptors with the
presence of elastic tissue within the tumour stroma
may have a similar explanation for there was a
statistical association between histological grade
and elastosis, the latter being most marked in well-
differentiated (grade I) tumours. Masters and his
colleagues (1976, 1978) and Rasmussen et al. (1981)
have also found an association between REC and
elastosis, a feature which occurs frequently in
postmenopausal patients, and an association has
been reported between RPC and elastosis (Rolland
et al., 1980). They could give no satisfying
explanation for their results.
Shivas & Douglas (1972) have shown that
patients whose tumours contain elastic tissue
survive longer than those who lack it. They are also
more likely to respond to endocrine therapy
(Masters et al., 1979). Well-differentiated (grade I)
tumours have similar properties (McGuire et al.,
1977). These reports taken with the present data
emphasise that hormone-dependent cells in breast
tumours can be demonstrated both biochemically
and histologically and many of the features of
breast cancer are interdependent. Steroid receptors
cannot be considered in isolation when planning
treatment.
The relationship between receptor status and
prognosis is not a simple one. Several reports have
suggested that early relapse of breast cancer is
clearly associated with a lack of RE, (Maynard et
al., 1978; Cooke et al., 1979, 1980; Allegra et al.,
1979; Hahnel et al., 1979; Forrest et al., 1980;
Westerberg et al., 1980). Patients who have REc are
reported to live longer than those who lack it
(Bishop et al., 1979; Croton et al., 1981). Kinne et
al. (1981) and Samaan et al. (1981) found no overall
difference in the RFS of patients with and without
REC but have found small significant differences in
subgroups based on node or menopausal status.
The data from the present study, like those of Hilf
et al. (1980) fails to demonstrate any clear
prognostic value for disease recurrence. Similarly
there is conflicting evidence that the progesterone
receptor is a reliable indicator of prognosis. Pichon
et al. (1980) demonstrated an increase in RFS for
patients with RPc whereas Allegra et al. (1979) and
Kinne et al. (1981) as in the present study, found no
association between the RPC and RFS.
The reasons for these conflicting results are not
clear. Variations in the method of receptor analysis
may be important and Forrest et al. (1980) showed
that by merely moving the "cut-off point"
separating receptor-rich (+ve) from receptor-poor
(low +ve and -ve) tumours, the prognostic value
for REC could be eliminated. However, there is
good qualitative agreement between centres using
the DCC technique, including our own (King et al.,
1978), and the present study has employed similar
criteria for receptor positivity to previous reports.
Hilf and his colleagues (1980) stressed that
clinical factors may cause confusion in interpreting
data relating REc status to prognosis, and their
observations may also apply to RPc. In early
studies numbers were small or receptor data from
primary and secondary tumours were combined. In
some, no allowance was made for patients receiving
additional systemic or local treatment following
mastectomy, in others, the status of the axillary
nodes was not accurately known, staging being
based on pectoral node biopsy, a technique which
in our experience may give a false-negative rate of
axillary node involvement as high as 20% (Howat
& Harris, 1982).
The length of follow-up is short in many of the
reports claiming prolonged RFS (Knight et al.,
1977; Maynard et al., 1978; Pichon et al., 1980),
and actual survival (Bishop et al., 1979; Croton et
al., 1981) for receptor +ve patients. Our experience
has emphasised the importance of prolonged follow-HORMONE RECEPTORS IN EARLY BREAST CANCER 639
up. At a median follow-up of 24 months our results
were similar to those of Knight et al. (1977),
Maynard et al. (1978) and Kinne et al. (1981). We
observed an increase in RFS for REc +ve patients
with lymph node involvement, but not for any other
sub-group. The data suggested that only those with
minimal axillary disease (1-3 nodes) benefitted and
it was thought that too few node -ve patients had
recurred to show any difference attributable to the
REC status and that patients with extensive nodal
involvement (.4) had recurred too rapidly for any
beneficial effect of REC to become apparent.
However, when the median follow-up reached 34
months the difference between REc +ve and RE,
-ve patients in the 1-3 node subgroup had
disappeared. Hahnel and his colleagues (1979) made
similar observations. An apparently advantageous
effect of the RE, in node +ve patients seen in the
first 2 years after mastectomy disappeared so that
at 5 years they too were unable to demonstrate a
significant difference between the RFS of REC +ve
and -ve patients in any subgroup. Von Maillot et
al. (1982) obtained similar results for both REC +ve
and RPc +ve patients when they were compared
with receptor-negative cases. Benson et al. (1982)
made similar observations on survival. At 5 years
there was no benefit for RE, +ve patients despite
an earlier trend in their favour.
It is not surprising that the progesterone receptor
did not influence the RFS in this study for its
presence is closely linked to that of REC. Thus one
might expect that the absence of any effect on RFS
of the REC would be reflected in the results
obtained with RPc.
As the data obtained in our study did not
demonstrate any marked prognostic value for either
REC or RPC status and as the presence of these
receptors may merely reflect more easily assessed
histological features, we conclude that the
measurement of these receptors is of no value in
identifying those patients at greatest risk of
recurrence. Other factors such as tumour size and
axillary node status remain pre-eminent as reliable
guides to prognosis.
The authors are grateful to Prof. R.A. Sellwood for
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Dr. A. Howell, Mr. R.N.L. Harland, Mr. M.J. Hudson and
Mr. L.G. Skinner, for their interest and invaluable advice
given during the preparation of this paper. Ms E.
Hayward gave expert technical assistance and Ms L.
Shaughnessy typed the manuscript.
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